India  

FDA Approves Over-the-Counter Overdose Medication

Video Credit: Wibbitz Top Stories - Duration: 01:31s - Published
FDA Approves Over-the-Counter Overdose Medication

FDA Approves Over-the-Counter Overdose Medication

FDA Approves , Over-the-Counter , Overdose Medication.

On March 29, the United States Food and Drug Administration (FDA) approved overdose reversal drug Narcan for over-the-counter use.

ABC reports that the decision marks a milestone that advocates say will save lives amid the ongoing opioid crisis.

Narcan is made by Emergent BioSolutions.

The drug is a nasal spray containing naloxone, which can restore breathing if someone is experiencing an opioid overdose.

.

According to medical experts, it is safe to administer the drug to anyone who appears to be having an overdose, even if it turns out they are not overdosing.

With the FDA's approval, the medication can now be sold in places like drug stores, grocery stores, convenience stores and even online.

With the FDA's approval, the medication can now be sold in places like drug stores, grocery stores, convenience stores and even online.

Today's approval of OTC naloxone nasal spray will help improve access to naloxone, increase the number of locations where it's available and help reduce opioid overdose deaths throughout the country, Dr. Robert M.

Califf, FDA Commissioner, via ABC.

We encourage the manufacturer to make accessibility to the product a priority by making it available as soon as possible and at an affordable price, Dr. Robert M.

Califf, FDA Commissioner, via ABC.

According to the Centers for Disease Control and Prevention, an estimated 107,622 drug overdose deaths occurred in 2021, setting a record high.

ABC reports that a majority of those deaths were the result of opioids, particularly synthetic forms of opioids like fentanyl.


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration United States federal agency

CDC and FDA Recommend Updated COVID Boosters for Everyone Over Six Months Old [Video]

CDC and FDA Recommend Updated COVID Boosters for Everyone Over Six Months Old

CDC and FDA Recommend , Updated COVID Boosters for , Everyone Over Six Months Old. 'The Independent' reports that updated COVID boosters from both Pfizer and Moderna are now available at pharmacies across the United States. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) both recommend one dose of an updated vaccine for everyone over six months old. Depending on their previous vaccination status, both agencies say some children may be eligible for up to three doses. . 'The Independent' reports that both hospitalizations and deaths have been on the rise in the U.S. for weeks. At the same time, health authorities around the world are monitoring the emergence of two new variants, BA.2.86, known as Pirola, and EG.5, known as Eris. According to data from the CDC, Eris is now responsible for almost 25% of U.S. COVID cases, after first being detected in February. Meanwhile, Pirola has triggered a surge in cases across a number of countries, including the U.S. . The CDC warns that unvaccinated individuals are more likely to get severely ill if they are infected with COVID. The National Institutes of Health (NIH) strongly recommend that pregnant women get the updated vaccine, citing a recent study. The small study cited by the NIH found “protective antibodies in nearly 75% of infants born to women who had been vaccinated during pregnancy.”

Credit: Wibbitz Top Stories    Duration: 01:31Published
DeSantis, Florida Surgeon General Contradict Federal COVID Booster Guidance [Video]

DeSantis, Florida Surgeon General Contradict Federal COVID Booster Guidance

DeSantis, Florida Surgeon General , Contradict Federal COVID Booster Guidance. On Sept. 11, the FDA approved a new COVID booster for anyone 6 months of age and older. The CDC recommended the new shots on Sept. 12. The vaccine is said to target Omicron subvariants that are spreading throughout the U.S. But Florida Gov. Ron DeSantis and Surgeon General Joseph A. Ladapo are advising the state's residents to not get the booster shot if they're under age 65, 'The Washington Post' reports. . The two men first made the comments during a live event last week and reiterated their claims during an X livestream on Sept. 13. . I will not stand by and let the FDA and CDC use healthy Floridians as guinea pigs for new booster shots that have not been proven to be safe or effective. No way FDA, Gov. Ron DeSantis, via X livestream. In December, DeSantis said he was forming a panel to counter the CDC's health recommendations, implying that the public has been misled about vaccine efficacy, 'The Washington Post' reports. . In May, he barred vaccine passports and mask requirements in schools and businesses. Ladapo has long been skeptical about COVID vaccines as well. In the past, his warnings were met with a public letter written by the FDA and CDC, . In the past, his warnings were met with a public letter written by the FDA and CDC, . saying that his comments were "incorrect, misleading and could be harmful to the American public," 'The Washington Post' reports.

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops [Video]

FDA Warns Companies to Stop Selling Potentially Dangerous, Unapproved Eye Drops

FDA Warns Companies to, Stop Selling Potentially Dangerous, , Unapproved Eye Drops. Gizmodo reports that the United States Food and Drug Administration (FDA) has warned several companies to stop selling unapproved eye drop products. On September 12, the FDA announced that it had issued warning letters to eight companies regarding the potentially dangerous products. The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products. The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products. The companies, including major retail chains CVS and Walgreens, have allegedly committed a number of violations by marketing or manufacturing these products. The FDA has also expressed concerns over silver compounds found in some of the products, which can turn people's skin or eyes blue with long-term use. According to the FDA, some of the eye drop products were allegedly manufactured at facilities that have failed to meet standard safety and quality guidelines. The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses, Food and Drug Administration, via statement. The FDA is particularly concerned that these illegally marketed, unapproved ophthalmic drug products pose a heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses, Food and Drug Administration, via statement. Gizmodo reports that the companies have 15 days to respond with their plans to correct the alleged violations. If the companies fail to respond, the FDA could take further action to either seize or stop the manufacturing of the products in question. When we identify illegally marketed, unapproved drugs and lapses in drug quality that pose potential risks, the FDA works to notify the companies involved of the violations, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo. We will continue to investigate potentially harmful eye products and work to ensure violative products stay off store shelves so that consumers can continue taking the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo. We will continue to investigate potentially harmful eye products and work to ensure violative products stay off store shelves so that consumers can continue taking the medicines they need without concern, Jill Furman, Director of the Office of Compliance for the FDA’s Center for Drug Evaluation and Research, via Gizmodo

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Says Popular Nasal Decongestant Not Effective Treatment For Congestion [Video]

FDA Says Popular Nasal Decongestant Not Effective Treatment For Congestion

FDA Says Popular , Nasal Decongestant , Not Effective Treatment For Congestion. Associated Press reports that government experts found that the number one decongestant in the United States does not alleviate a stuffy nose. . Associated Press reports that government experts found that the number one decongestant in the United States does not alleviate a stuffy nose. . On September 12, advisers for the Food and Drug Administration voted unanimously against the effectiveness of phenylephrine. Phenylephrine is found in a number of popular over-the-counter products, including Sudafed, Allegra and Dayquil. Modern studies, when well conducted, are not showing any improvement in congestion with phenylephrine, Dr. Mark Dykewicz, Allergy specialist at the Saint Louis University School of Medicine, via Associated Press. AP reports that a team of outside advisers were assembled by the FDA to take a closer look at the effectiveness of phenylephrine. Phenylephrine became the key ingredient in decongestants in 2006, when pseudoephedrine was ordered to be moved behind pharmacy counters. Phenylephrine became the key ingredient in decongestants in 2006, when pseudoephedrine was ordered to be moved behind pharmacy counters. The change came after a 2006 law called for the change, as pseudoephedrine can be used to produce methamphetamine. . The change came after a 2006 law called for the change, as pseudoephedrine can be used to produce methamphetamine. . AP reports that pending the FDA's decision, drugmakers like Johnson & Johnson and Bayer could be ordered to pull oral medications with phenylephrine. . AP reports that pending the FDA's decision, drugmakers like Johnson & Johnson and Bayer could be ordered to pull oral medications with phenylephrine. . According to the FDA's panel of experts, consumers would need to be educated on remaining options for treating congestion. Patients require and deserve medications that treat their symptoms safely and effectively and I don’t believe that this medication does that, Jennifer Schwartzott, the patient representative on the FDA panel, via Associated Press

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Approves New COVID Boosters Ahead of Expected Winter Surge in Cases [Video]

FDA Approves New COVID Boosters Ahead of Expected Winter Surge in Cases

FDA Approves New COVID Boosters , Ahead of Expected Winter Surge in Cases. On September 11, the United States Food and Drug Administration approved updated COVID boosters from both Pfizer and Moderna. NBC reports that the new boosters are specifically formulated to target the XBB.1.5 subvariant. . The updated shots are expected to be available later this week, pending the approval of the Centers for Disease Control and Prevention. According to the FDA, anyone over the age of five is eligible to receive either company's booster shot, regardless of if they were previously vaccinated. The FDA also advised that vaccinated individuals should wait at least two months before receiving the updated booster. . NBC reports that the news comes as the U.S. faces a rising number of cases, as a result of a number of new subvariants. Officials have expressed hope that the new boosters could potentially stave off a spike in winter infections. . On September 12, a CDC advisory committee is scheduled to convene for a vote on recommendations for who should receive the booster. . On September 12, a CDC advisory committee is scheduled to convene for a vote on recommendations for who should receive the booster. . NBC reports that CDC Director Dr. Mandy Cohen is expected to approve those recommendations, opening the door for vaccinations to begin. NBC reports that CDC Director Dr. Mandy Cohen is expected to approve those recommendations, opening the door for vaccinations to begin. According to experts, those who haven't had a booster since last fall, as well as those who haven't had a recent case of COVID, should get the booster as soon as possible.

Credit: Wibbitz Top Stories    Duration: 01:31Published

Related videos from verified sources

California Announces Contract to Produce Its Own Affordable Insulin [Video]

California Announces Contract to Produce Its Own Affordable Insulin

California Announces Contract , to Produce Its Own Affordable Insulin. CBS News reports that on March 18, Gov. Gavin Newsom announced that California has struck a 10-year deal with nonprofit drug..

Credit: Wibbitz Top Stories     Duration: 01:31Published